BURLONE, MICHELA Emma
BURLONE, MICHELA Emma
Dipartimento di Medicina Traslazionale
17β-Oestradiol Protects from Hepatitis C Virus Infection through Induction of Type I Interferon
2022-01-01 Barbaglia, Matteo Nazzareno; Harris, James Michael; Smirnov, Artem; Burlone, Michela Emma; Rigamonti, Cristina; Pirisi, Mario; Minisini, Rosalba; Magri, Andrea
[Therapeutic decisions and treatment with sorafenib in hepatocellular carcinoma: final analysis of GIDEON study in Italy]
2015-01-01 D'Angelo, Salvatore; Germano, Domenico; Zolfino, Teresa; Sansonno, Domenico; Giannitrapani, Lydia; Benedetti, Antonio; Montesarchio, Vincenzo; Attili, Adolfo; Buonadonna, Angela; Barni, Sandro; Gasbarrini, Antonio; Burlone, MICHELA Emma; Cillo, Umberto; Marenco, Simona; Villa, Erica; Giovanis, Petros; Proserpio, Ilaria; Saitta, Carlo; Magini, Giulia; Cengarle, Rita; Fava, Giammarco; Cuttone, Filiana; Calvani, Nicola; Angelico, Mario; Di Costanzo, Francesco; Noto, Alfonso; Poggi, Guido; Marignani, Massimo; Cascinu, Stefano; Amoroso, Domenico; Palmieri, Vincenzo; Massa, Elena; Crocè, Lory Saveria; Picardi, Antonio; Tumulo, Salvatore; Erminero, Claudia; Lencioni, Riccardo; Lorusso, Vito
B2-Lymphocyte responses to oxidative stress-derived antigens contribute to the evolution of nonalcoholic fatty liver disease (NAFLD)
2018-01-01 Bruzzì, Stefania; Sutti, Salvatore; Giudici, Gabriele; Burlone, Michela E.; Ramavath, NARESH NAIK; Toscani, Alberto; Bozzola, Cristina; Schneider, Pascal; Morello, Elisabetta; Parola, Maurizio; Pirisi, Mario; Albano, Emanuele
B2-Lymphocyte responses to oxidative stress-derived antigens contribute to the evolution of nonalcoholic fatty liver disease (NAFLD)
2018-01-01 Bruzzì, Stefania; Sutti, Salvatore; Giudici, Gabriele; Burlone, Michela E; Ramavath, Naresh Naik; Toscani, Alberto; Bozzola, Cristina; Schneider, Pascal; Morello, Elisabetta; Parola, Maurizio; Pirisi, Mario; Albano, Emanuele
Cardiac dysfunction as an early predictor of portal hypertension in chronic hepatitis C
2017-01-01 Marconi, Cecilia; Bellan, Mattia; Giarda, Paola; Minisini, Rosalba; Favretto, Serena; Burlone, Michela Emma; Franzosi, Lisa; Pirisi, Mario
Delivering adjuvant and neoadjuvant treatments in the early stages of hepatocellular carcinoma
2024-01-01 Stefanini, Bernardo; Manfredi, Giulia F.; D'Alessio, Antonio; Fulgenzi, Claudia A. M.; Awosika, Nichola; Celsa, Ciro; Pirisi, Mario; Rigamonti, Cristina; Burlone, Michela; Vincenzi, Federica; Minisini, Rosalba; Gennari, Alessandra; Yip, Vincent; Slater, Sarah; El-Shakankery, Karim; Jain, Ananya; Tovoli, Francesco; Piscaglia, Fabio; Spalding, Duncan; Pai, Madhava; Pinato, David J.
Direct antivirals and cognitive impairment in hepatitis C: a clinical-neurophysiologic study
2020-01-01 Vaghi, G.; Gori, B.; Strigaro, G.; Burlone, M.; Minisini, R.; Barbaglia, M. N.; Brigatti, E.; Varrasi, C.; Pirisi, M.; Cantello, R.
Evaluation of the red cell distribution width as a biomarker of early mortality in hepatocellular carcinoma
2015-01-01 Smirne, Carlo; Grossi, Glenda; Pinato, David J; Burlone, MICHELA Emma; Mauri, Francesco A; Januszewski, Adam; Oldani, Alberto; Minisini, Rosalba; Sharma, Rohini; Pirisi, Mario
Fibrosis Progression in HCV Carriers with Mild Hepatitis Who Possess the High-Repetition Variant of the DRD4 Gene, a Genetic Marker for Binge-Drinking and Risk-Seeking Behavior: A Longitudinal Study.
2013-01-01 Minisini, Rosalba; Boccato, E; Favretto, Serena; Alaimo, E; Smirne, Carlo; Burlone, MICHELA Emma; Bocchetta, S; Vandelli, C; Colletta, C; Colletta, A; Pirisi, Mario
Gas6/TAM Signaling Components as Novel Biomarkers of Liver Fibrosis
2019-01-01 Smirne, C.; Rigamonti, C.; DE BENEDITTIS, Carla; Sainaghi, P. P.; Bellan, M.; Burlone, M. E.; Castello, L. M.; Avanzi, G. C.
GENETIC POLYMORPHISM AT THE APOLIPOPROTEIN E LOCUS AFFECTS THE OUTCOME OF CHRONIC HEPATITIS B
2010-01-01 Toniutto, P; Fattovich, G; Fabris, C; Minisini, Rosalba; Burlone, MICHELA Emma; Pravadelli, C; Peraro, L; Falleti, E; Caldera, F; Bitetto, D; Pirisi, Mario
HBV AND LYMPHOMAGENESIS: NOVEL INSIGHTS INTO AN OCCULT RELATIONSHIP
2011-01-01 Burlone, MICHELA Emma; Tran Minh, M.; Pinato, D. J.; Boccato, E.; Rossi, Davide; Minisini, R.; Gaidano, Gianluca; Pirisi, Mario
Hepatic decompensation is the major driver of mortality in hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: The impact of successful antiviral treatment
2024-01-01 Celsa, Ciro; Cabibbo, Giuseppe; Fulgenzi, Claudia Angela Maria; Battaglia, Salvatore; Enea, Marco; Scheiner, Bernhard; D'Alessio, Antonio; Manfredi, Giulia F.; Stefanini, Bernardo; Nishida, Naoshi; Galle, Peter R.; Schulze, Kornelius; Wege, Henning; Ciccia, Roberta; Hsu, Wei-Fan; Vivaldi, Caterina; Wietharn, Brooke; Lin, Ryan Po-Ting; Pirozzi, Angelo; Pressiani, Tiziana; Dalbeni, Andrea; Natola, Leonardo A.; Auriemma, Alessandra; Rigamonti, Cristina; Burlone, Michela; Parisi, Alessandro; Huang, Yi-Hsiang; Lee, Pei-Chang; Ang, Celina; Marron, Thomas U.; Pinter, Matthias; Cheon, Jaekyung; Phen, Samuel; Singal, Amit G; Gampa, Anuhya; Pillai, Anjana; Roehlen, Natascha; Thimme, Robert; Vogel, Arndt; Soror, Noha; Ulahannan, Susanna; Sharma, Rohini; Sacerdoti, David; Pirisi, Mario; Rimassa, Lorenza; Lin, Chun-Yen; Saeed, Anwaar; Masi, Gianluca; Schönlein, Martin; von Felden, Johann; Kudo, Masatoshi; Cortellini, Alessio; Chon, Hong Jae; Cammà, Calogero; Pinato, David James
Hepatitis C virus cell entry: role of lipoproteins and cellular receptors.
2009-01-01 Burlone, MICHELA Emma; Budkowska, A.
HSD17B13 and other liver fat-modulating genes predict development of hepatocellular carcinoma among HCV-positive cirrhotics with and without viral clearance after DAA treatment
2022-01-01 Burlone, M. E.; Bellan, M.; Barbaglia, M. N.; Mocchetti, G.; Mallela, V. R.; Minisini, R.; Rigamonti, C.; Pirisi, M.
Identification of mutations in circulating cell-free tumour DNA as a biomarker in hepatocellular carcinoma
2019-01-01 Howell, J.; Atkinson, S. R.; Pinato, D. J.; Knapp, S.; Ward, C.; Minisini, R.; Burlone, M. E.; Leutner, M.; Pirisi, M.; Buttner, R.; Khan, S. A.; Thursz, M.; Odenthal, M.; Sharma, R.
Identification of the Best Cut-Off Value of PIVKA-II for the Surveillance of Patients at Risk of Hepatocellular Carcinoma Development
2023-01-01 Caviglia, Gian Paolo; Abate, Maria Lorena; Troshina, Giulia; Carucci, Patrizia; Rolle, Emanuela; Risso, Alessandra; Burlone, Michela Emma; Albè, Alice; Crevola, Martina; Musso, Emma Clara; Rosso, Chiara; Armandi, Angelo; Olivero, Antonella; Minisini, Rosalba; Saracco, Giorgio Maria; Bugianesi, Elisabetta; Pirisi, Mario; Ciancio, Alessia; Gaia, Silvia
IL28B Polymorphism, Blood Interferon-alpha Concentration, and Disease Stage of HCV Mono-infected and HCV-HIV Co-infected Patients.
2013-01-01 Burlone, MICHELA Emma; Cerutti, A; Minisini, Rosalba; Smirne, Carlo; Boccato, E; Ceriani, E; Rizzo, G; Bargiacchi, O; Bocchetta, S; Occhino, G; Pirisi, Mario
Improvement of insulin sensitivity in diabetic and non diabetic patients with chronic hepatitis C treated with direct antiviral agents
2018-01-01 Gualerzi, Alessandro; Bellan, Mattia; Smirne, Carlo; TRAN MINH, Margherita; Rigamonti, Cristina; Burlone, Michela Emma; Bonometti, Ramona; Bianco, Sara; Re, Azzurra; Favretto, Serena; Bellomo, Giorgio; Minisini, Rosalba; Carnevale Schianca, Gian Piero; Pirisi, Mario
Influence of age on sex-related differences among patients with hepatitis C.
2016-01-01 Burlone, MICHELA Emma; Pedrinelli, Anita Rebecca; Giarda, Paola; Minisini, Rosalba; Pirisi, Mario
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 17β-Oestradiol Protects from Hepatitis C Virus Infection through Induction of Type I Interferon | 1-gen-2022 | Barbaglia, Matteo Nazzareno; Harris, James Michael; Smirnov, Artem; Burlone, Michela Emma; Rigamonti, Cristina; Pirisi, Mario; Minisini, Rosalba; Magri, Andrea | |
| [Therapeutic decisions and treatment with sorafenib in hepatocellular carcinoma: final analysis of GIDEON study in Italy] | 1-gen-2015 | D'Angelo, Salvatore; Germano, Domenico; Zolfino, Teresa; Sansonno, Domenico; Giannitrapani, Lydia; Benedetti, Antonio; Montesarchio, Vincenzo; Attili, Adolfo; Buonadonna, Angela; Barni, Sandro; Gasbarrini, Antonio; Burlone, MICHELA Emma; Cillo, Umberto; Marenco, Simona; Villa, Erica; Giovanis, Petros; Proserpio, Ilaria; Saitta, Carlo; Magini, Giulia; Cengarle, Rita; Fava, Giammarco; Cuttone, Filiana; Calvani, Nicola; Angelico, Mario; Di Costanzo, Francesco; Noto, Alfonso; Poggi, Guido; Marignani, Massimo; Cascinu, Stefano; Amoroso, Domenico; Palmieri, Vincenzo; Massa, Elena; Crocè, Lory Saveria; Picardi, Antonio; Tumulo, Salvatore; Erminero, Claudia; Lencioni, Riccardo; Lorusso, Vito | |
| B2-Lymphocyte responses to oxidative stress-derived antigens contribute to the evolution of nonalcoholic fatty liver disease (NAFLD) | 1-gen-2018 | Bruzzì, Stefania; Sutti, Salvatore; Giudici, Gabriele; Burlone, Michela E.; Ramavath, NARESH NAIK; Toscani, Alberto; Bozzola, Cristina; Schneider, Pascal; Morello, Elisabetta; Parola, Maurizio; Pirisi, Mario; Albano, Emanuele | |
| B2-Lymphocyte responses to oxidative stress-derived antigens contribute to the evolution of nonalcoholic fatty liver disease (NAFLD) | 1-gen-2018 | Bruzzì, Stefania; Sutti, Salvatore; Giudici, Gabriele; Burlone, Michela E; Ramavath, Naresh Naik; Toscani, Alberto; Bozzola, Cristina; Schneider, Pascal; Morello, Elisabetta; Parola, Maurizio; Pirisi, Mario; Albano, Emanuele | |
| Cardiac dysfunction as an early predictor of portal hypertension in chronic hepatitis C | 1-gen-2017 | Marconi, Cecilia; Bellan, Mattia; Giarda, Paola; Minisini, Rosalba; Favretto, Serena; Burlone, Michela Emma; Franzosi, Lisa; Pirisi, Mario | |
| Delivering adjuvant and neoadjuvant treatments in the early stages of hepatocellular carcinoma | 1-gen-2024 | Stefanini, Bernardo; Manfredi, Giulia F.; D'Alessio, Antonio; Fulgenzi, Claudia A. M.; Awosika, Nichola; Celsa, Ciro; Pirisi, Mario; Rigamonti, Cristina; Burlone, Michela; Vincenzi, Federica; Minisini, Rosalba; Gennari, Alessandra; Yip, Vincent; Slater, Sarah; El-Shakankery, Karim; Jain, Ananya; Tovoli, Francesco; Piscaglia, Fabio; Spalding, Duncan; Pai, Madhava; Pinato, David J. | |
| Direct antivirals and cognitive impairment in hepatitis C: a clinical-neurophysiologic study | 1-gen-2020 | Vaghi, G.; Gori, B.; Strigaro, G.; Burlone, M.; Minisini, R.; Barbaglia, M. N.; Brigatti, E.; Varrasi, C.; Pirisi, M.; Cantello, R. | |
| Evaluation of the red cell distribution width as a biomarker of early mortality in hepatocellular carcinoma | 1-gen-2015 | Smirne, Carlo; Grossi, Glenda; Pinato, David J; Burlone, MICHELA Emma; Mauri, Francesco A; Januszewski, Adam; Oldani, Alberto; Minisini, Rosalba; Sharma, Rohini; Pirisi, Mario | |
| Fibrosis Progression in HCV Carriers with Mild Hepatitis Who Possess the High-Repetition Variant of the DRD4 Gene, a Genetic Marker for Binge-Drinking and Risk-Seeking Behavior: A Longitudinal Study. | 1-gen-2013 | Minisini, Rosalba; Boccato, E; Favretto, Serena; Alaimo, E; Smirne, Carlo; Burlone, MICHELA Emma; Bocchetta, S; Vandelli, C; Colletta, C; Colletta, A; Pirisi, Mario | |
| Gas6/TAM Signaling Components as Novel Biomarkers of Liver Fibrosis | 1-gen-2019 | Smirne, C.; Rigamonti, C.; DE BENEDITTIS, Carla; Sainaghi, P. P.; Bellan, M.; Burlone, M. E.; Castello, L. M.; Avanzi, G. C. | |
| GENETIC POLYMORPHISM AT THE APOLIPOPROTEIN E LOCUS AFFECTS THE OUTCOME OF CHRONIC HEPATITIS B | 1-gen-2010 | Toniutto, P; Fattovich, G; Fabris, C; Minisini, Rosalba; Burlone, MICHELA Emma; Pravadelli, C; Peraro, L; Falleti, E; Caldera, F; Bitetto, D; Pirisi, Mario | |
| HBV AND LYMPHOMAGENESIS: NOVEL INSIGHTS INTO AN OCCULT RELATIONSHIP | 1-gen-2011 | Burlone, MICHELA Emma; Tran Minh, M.; Pinato, D. J.; Boccato, E.; Rossi, Davide; Minisini, R.; Gaidano, Gianluca; Pirisi, Mario | |
| Hepatic decompensation is the major driver of mortality in hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: The impact of successful antiviral treatment | 1-gen-2024 | Celsa, Ciro; Cabibbo, Giuseppe; Fulgenzi, Claudia Angela Maria; Battaglia, Salvatore; Enea, Marco; Scheiner, Bernhard; D'Alessio, Antonio; Manfredi, Giulia F.; Stefanini, Bernardo; Nishida, Naoshi; Galle, Peter R.; Schulze, Kornelius; Wege, Henning; Ciccia, Roberta; Hsu, Wei-Fan; Vivaldi, Caterina; Wietharn, Brooke; Lin, Ryan Po-Ting; Pirozzi, Angelo; Pressiani, Tiziana; Dalbeni, Andrea; Natola, Leonardo A.; Auriemma, Alessandra; Rigamonti, Cristina; Burlone, Michela; Parisi, Alessandro; Huang, Yi-Hsiang; Lee, Pei-Chang; Ang, Celina; Marron, Thomas U.; Pinter, Matthias; Cheon, Jaekyung; Phen, Samuel; Singal, Amit G; Gampa, Anuhya; Pillai, Anjana; Roehlen, Natascha; Thimme, Robert; Vogel, Arndt; Soror, Noha; Ulahannan, Susanna; Sharma, Rohini; Sacerdoti, David; Pirisi, Mario; Rimassa, Lorenza; Lin, Chun-Yen; Saeed, Anwaar; Masi, Gianluca; Schönlein, Martin; von Felden, Johann; Kudo, Masatoshi; Cortellini, Alessio; Chon, Hong Jae; Cammà, Calogero; Pinato, David James | |
| Hepatitis C virus cell entry: role of lipoproteins and cellular receptors. | 1-gen-2009 | Burlone, MICHELA Emma; Budkowska, A. | |
| HSD17B13 and other liver fat-modulating genes predict development of hepatocellular carcinoma among HCV-positive cirrhotics with and without viral clearance after DAA treatment | 1-gen-2022 | Burlone, M. E.; Bellan, M.; Barbaglia, M. N.; Mocchetti, G.; Mallela, V. R.; Minisini, R.; Rigamonti, C.; Pirisi, M. | |
| Identification of mutations in circulating cell-free tumour DNA as a biomarker in hepatocellular carcinoma | 1-gen-2019 | Howell, J.; Atkinson, S. R.; Pinato, D. J.; Knapp, S.; Ward, C.; Minisini, R.; Burlone, M. E.; Leutner, M.; Pirisi, M.; Buttner, R.; Khan, S. A.; Thursz, M.; Odenthal, M.; Sharma, R. | |
| Identification of the Best Cut-Off Value of PIVKA-II for the Surveillance of Patients at Risk of Hepatocellular Carcinoma Development | 1-gen-2023 | Caviglia, Gian Paolo; Abate, Maria Lorena; Troshina, Giulia; Carucci, Patrizia; Rolle, Emanuela; Risso, Alessandra; Burlone, Michela Emma; Albè, Alice; Crevola, Martina; Musso, Emma Clara; Rosso, Chiara; Armandi, Angelo; Olivero, Antonella; Minisini, Rosalba; Saracco, Giorgio Maria; Bugianesi, Elisabetta; Pirisi, Mario; Ciancio, Alessia; Gaia, Silvia | |
| IL28B Polymorphism, Blood Interferon-alpha Concentration, and Disease Stage of HCV Mono-infected and HCV-HIV Co-infected Patients. | 1-gen-2013 | Burlone, MICHELA Emma; Cerutti, A; Minisini, Rosalba; Smirne, Carlo; Boccato, E; Ceriani, E; Rizzo, G; Bargiacchi, O; Bocchetta, S; Occhino, G; Pirisi, Mario | |
| Improvement of insulin sensitivity in diabetic and non diabetic patients with chronic hepatitis C treated with direct antiviral agents | 1-gen-2018 | Gualerzi, Alessandro; Bellan, Mattia; Smirne, Carlo; TRAN MINH, Margherita; Rigamonti, Cristina; Burlone, Michela Emma; Bonometti, Ramona; Bianco, Sara; Re, Azzurra; Favretto, Serena; Bellomo, Giorgio; Minisini, Rosalba; Carnevale Schianca, Gian Piero; Pirisi, Mario | |
| Influence of age on sex-related differences among patients with hepatitis C. | 1-gen-2016 | Burlone, MICHELA Emma; Pedrinelli, Anita Rebecca; Giarda, Paola; Minisini, Rosalba; Pirisi, Mario |